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ABSTRACT
Hibernation, a natural model of tolerance to “cerebral ischemia”, represents a 
state of pronounced fluctuation in cerebral blood flow where no brain damage occurs. 
This study systematically investigates the brain tissue response of hibernating and 
euthermic arctic ground squirrels to CNS trauma, modeled by insertion of microdialysis 
probes. The effect of glutamate, an excitatory amino acid neurotransmitter, on the 
cellular response and the origin of the significant amount of glutamate were determined 
by quantitative microdialysis study.
The present results indicate in euthermic brain tissue a typical inflammatory tissue 
response evidenced by the presence of activated microglia and astrocytes and the 
oxidative stress response. However, this response was profoundly suppressed in 
hibernating animals. Importantly, the progressive increase in [glu]dia is not necessarily 
associated with the enhanced tissue response observed in euthermic animals and could be 
avoided by using sterile microdialysis technique, which suggests a microbial origin of 
glutamate.
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1CHAPTER 1 
INTRODUCTION
1.1. Stroke and Traumatic Brain Injury
Stroke, the consequence of an interruption of cerebral blood flow, is the third 
most common cause of death in North America and the leading cause of long-term 
disability in the United States (National Stroke Association, 1994). Estimates indicate an 
incidence of approximately 750,000 strokes per year in the United States, with about 4 
million survivors who are at high risk of a secondary cardiovascular event. Researchers 
from the University of Iowa College of Medicine at American Heart Association’s 23rd 
International Joint Conference on Stroke and Cerebral Circulation (Orlando, Fla.) 
reported that by the year 2050 more than 1 million strokes per year are expected in the 
United States. Overall, stroke represents a large unmet medical need (Fisher and 
Bogousslawsky, 1998).
Clinical and experimental studies show that following an acute ischemic stroke, 
neuronal damage continues to progress for periods of several hours to days (Petito et al., 
1987; Heiss et al., 1992; Garcia, 1992). This time period is seen as a window of 
opportunity to allay neuronal damage. Elevated extracellular concentrations of glutamate 
following cerebral ischemia are thought to mediate the pathological process that 
eventually results in cell death (Choi and Rothman, 1990). However, to date, there is no 
medical treatment approved for stroke beyond the tissue plasminogen activator (t-PA), a
thrombolytic agent restricted to administration within 3 hours after stroke (The NINDS 
rt-PA Study Group, 1995; Wahlgren, 1997)
Traumatic brain injury (TBI) is the most important cause of death for young 
adults in the United States (Goldstein, 1990) and the incidence of TBI is increasing.
After a severe head injury around 40% of patients will die, and of the remainder, 15% to 
70% remain disabled (Bullock and Teasdale, 1990).
The clinical characteristics of TBI include elevated intracranial pressure (ICP) 
(Lundberg N et al., 1965), reduced cerebral blood flow (particularly focal or regional 
flow reduced to levels that likely represent ischemia) and decreased cerebral metabolic 
demands (Bouma et al., 1991; Robertson et al., 1992; Salvant and Muizelaar, 1993). 
High levels of glutamate have been observed following TBI (Faden et al., 1989). 
Contemporary treatment strategies for TBI are directed toward treating secondary brain 
injury which involves multiple biochemical and cellular events, such as elevated 
excitatory amino acids (eg. glutamate), increases in intracellular calcium, acidosis and 
free radicals (Bullock and Fujisawa, 1992; Katayama et al., 1990; Kontos, 1989; Hall, 
1993; Wolf etal., 1993). However, the mechanisms underlying secondary or delayed 
cell death, progressing from hours to days after initial insult, still has to be fully 
elucidated.
1.2. Excitotoxicity
Excitatory amino acids (EAAs) normally function as neurotransmitters but are 
known to mediate excitotoxicity in high concentrations. Glutamate is such a
2
3neurotransmitter present in excitatory presynaptic terminals throughout the brain. The 
neurotoxicity of glutamate in the brain was established 30 years ago (Olney and Sharpe, 
1969) and supported by a number of studies based on glutamate neurotransmission 
(Curtis and Johnston, 1974; Choi, 1988).
The human brain depends on its blood supply of oxygen and glucose. Irreversible 
brain damage occurs in only a few minutes if blood flow is highly reduced or completely 
interrupted. Such reduction (ischemia) is common in some diseases, such as ischemic 
stroke, TBI, and a variety of neurological disorders (Choi and Rothman, 1990). The 
reduction in blood flow and consequent decline in ATP levels lead to membrane 
depolarization, which in turn results in the opening of voltage-operated calcium channels 
(VOCCs) and Ca2+ influx into the cells (Hass, 1983). This increase in Ca2+ 
presynaptically causes the release of glutamate that acts on its several families of 
postsynaptic receptors (NMDA, AMPA and kainate), especially NMDA receptors, and
O j ^  I
results in further influx postsynaptically of Ca as well as the mobilization of Ca from 
intracellular stores (Fransden and Schousboe, 1991). It is generally accepted that 
excitotoxic injury to neurons results from these high levels of intracellular Ca , which 
can overstimulate Ca2+-dependent enzymes, such as phospholipases, proteinase and 
endonucleases (Sims, 1995). This may lead to immediate or delayed cell death (Lipton 
and Rosenberg, 1994). Recently it has been revealed that accumulation of intracellular 
Ca2+ plays a pivotal role in both of the two major pathways (apoptosis and necrosis) of 
ischemic cell death (Zipfel et al., 2000).
4The discoveries of increased extracellular levels of glutamate during ischemia 
(Benveniste et al., 1984) and the beneficial effect of NMDA-receptor antagonists in the 
model of neurological disorders (Faden et al., 1989; McCulloch et al., 1993) are often 
used to support the neurotoxicity of glutamate. However, more recently, reports on 
glutamate neurotoxicity have been subjected to intensive debate (Obrenovitch and 
Urenjak, 1997). The arguments against the systematic interpretation of glutamate 
excitotoxicity focus on: 1) increased concentrations of extracellular glutamate should not 
be taken as a reliable indicator of excitotoxicity; 2 ) the beneficial effect of glutamate 
antagonists does not necessarily imply an excitotoxic process (Obrenovitch, 1999).
1.3. Inflammatory Response
The brain has no intrinsic immune system since a very effective blood brain 
barrier (BBB) system inhibits free access of blood cells to the brain tissue. However, 
microglia, astrocytes and perivascular cells form a network of potential immune cells 
throughout the CNS (Berry and Logan, 1999; Gehrmann et al., 1995). CNS damage 
elicits the activation of both astrocytes and microglia (Streit et al., 1999).
Microglia, the small glial cells of mesodermal origin, derive from monocytes and 
invade neural tissue just before birth. Microglia are the special name of resting 
macrophages inside the CNS and they are ubiquitous in every part of the CNS and 
essential for maintaining normal homeostasis (Berry and Logan, 1999). Although little is 
known about microglia in the normal CNS, it is obvious that microglia readily become 
activated in response to CNS injuries or neurodegenerative diseases, including
5Alzheimer’s disease, Parkinson’s disease, multiple sclerosis and AIDs dementia complex. 
Activation of microglia is indicated by a morphological change from a ramified resting 
state to an amoeboid activate appearance (Streit et al., 1988; Krentzberg, 1996). They 
are the primary source of brain macrophages.
The activation of microglia is believed to contribute to neurodegenerative 
processes through the release of proinflammatory and/or cytotoxic factors, including 
interleukin-1 (IL-1), turmor necrosis factor-a (TNFa), nitric oxide (NO), reactive oxygen 
intermediates and quinolinic acid (Chao et al., 1992; Dickson et al., 1993; Lee et al., 
1993; Matsumoto et al., 1992; Espey et al., 1997). Furthermore, activation of microglia 
and subsequent production of proinflammatory and cytotoxic factors have been attributed 
to increased neurotoxicity (Chao et al., 1992; Dawson et al., 1993).
Microglia activation occurs at a very early stage and often precedes reaction of 
any other cell type in the event of pathological disturbances (Streit et al., 1988;
Gehrmam et al., 1995). Therefore they form the first line of defense and are in control of 
immune response in the brain. It has been demonstrated that a variety of immunological 
surface marker molecules are expressed on the surface of activated microglia (Morioka et 
al., 1992; Kato et al., 1995). With the introduction of lectin histochemistry, the rapid and 
high specific biotin-avidin marker system made it possible to show both resting and 
activated microglia by using the lectin RCA-1, a carbohydrate binding protein, as 
detected with the avidin-biotin peroxidase method (Mannoji et al., 1986).
Astrocytes are ubiquitous in the brain and amount to 20% of the total cell volume 
of the cerebral cortex. They have multiple functions including the transport of blood
6cells and nutrients through the BBB and more importantly, maintain ion homeostasis 
(Rosenman et al., 1995; Varon and Somjen, 1979). Following CNS injuries, such as 
trauma, disease or chemical insult, astrocytes become reactive, termed astrogliosis. It is 
now well established that glial fibrillary acidic protein (GFAP) is the principle 
intermediate filament in mature astrocytes of CNS and is important in modulating 
astrocyte motility and shape. Astrogliosis is characterized by rapid synthesis of GFAP 
and is recognized by immunostaining with GFAP antibody. Therefore, GFAP has been 
recognized as a standard marker for activated astrocytes (for review see Eng et al., 2000).
1.4. Hibernation and Neuroprotection
Hibernation is a unique physiological condition characterized by a decrease in 
body temperature, heart and respiration rate, reduction in blood flow and suppression of 
metabolism. The ability of hibernating mammals to survive without neurological damage 
during dramatic fluctuations in blood flow represents a natural model of tolerance to 
cerebral ischemia (Frerichs et al., 1994). Moreover, an vitro study indicated that 
hibernation is associated with tolerance to deprivation of oxygen and glucose (Frerichs 
and Hallenbeck, 1998). This increased tolerance may arise from a variety of 
neuroprotective adaptations. Study of hibernation as a model of tolerance to brain trauma 
may provide directions for the treatment of neuronal damage in CNS trauma or 
neurodegenerative diseases.
Hypothermia is the first to be considered as such a neuroprotective aspect.
During the period of torpor from several days to weeks, hibernating mammals survive
well at core body temperature around 3 °C, which is harmful to non-hibernating species 
including humans. Experimental studies provide evidence of an association between 
hypothermia and reduced neuronal injury after ischemia or TBI (Busto et al., 1987). But 
data in humans is still limited and controversial (Marion et al., 1997; Clifton et al., 2001).
Leukocytopenia may be another remarkable neuroprotective adaptation. 
Leukocyte counts in hibernating arctic ground squirrels dramatically decrease to about 
one tenth euthermic values and rapidly increase to euthermic levels during arousal (Zhou 
et al., 2001; Toien et al., 2001). Although the mechanism of this dramatic change in 
leukocytes is not yet fully understood, it appears obvious that leukocyte infiltration at 
sites of injury promotes cytotoxic reactions (Bowes et al., 1993; Whalen et al., 2000). 
Thus leukocytopenia may serve a neuroprotective role during hibernation.
Neuronal damage is more than the passive outcome of reducing the oxygen 
supply for adequate energy production to allow survival. Increasing evidence indicates 
that much of the damage is mediated by active processes such as production of radicals 
and other oxidizing chemical species (for review see Love, 1999). Oxidative stress, an 
imbalance between the production of free radicals and the cellular antioxidant response, 
also contributes to neurological disorders (Smith et al., 2000). The enhanced antioxidant 
defense during hibernation may provide another important role in neuroprotection (Drew 
et al., 1999; Toein et al., 2000). The plasma and CSF concentrations of ascorbate 
(vitamin C), an antioxidant, increase during the period of hibernation. This may protect 
brain tissue against oxidative stress associated with the fluctuation of blood flow (Drew 
et al., 1999). In addition to hypothermia, leukocytopenia and increased antioxidant
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defense, some other aspects of hibernation physiology, like the inhibition of protein 
synthesis (Frerichs et al., 1998), and suppression of metabolism (Storey, 1997), may also 
contribute to other neuroprotective adaptations. Overall, hibernating species are likely to 
utilize a combination of physiological adaptations during hibernation to minimize the 
energy demand and neuronal damage resulting from a variety of pathological disorders. 
Most single neuroprotective treatment used in clinical trial show no clinical efficacy.
This promises new drugs in clinical development which may involve a variety of 
synergistic adaptations (Walgren et al., 1997).
1.5. Scope and Aims
The broad goal of the work in this thesis is to investigate neuroprotection in 
hibernating mammals. The main aims in this study are:
1. To test the hypothesis that hibernating brain tissue is tolerant to penetrating 
brain injury.
2. To test the hypothesis that an increase in extracellular glutamate is necessary 
for progressive traumatic tissue response observed in euthermic animals in aim 1.
3. To investigate the origin of increased extracellular glutamate associated with 
traumatic tissue response.
9CHAPTER 2 
METHODOLOGY 
2.1. Animals
Hibernating mammals withstand extreme fluctuation of cerebral blood flow 
without neurological damage, and are used as a model of natural tolerance to ischemia 
(Frerichs et al., 1994). Arctic ground squirrels (AGS) are such hibernating species and 
therefore used in the present studies to investigate neuroprotective functions. AGS were 
live-trapped in northern Alaska and transported to the Institute of Arctic Biology, 
University of Alaska Fairbanks. Male and female ground squirrels weighing 650- 840 g 
were housed individually in a temperature-controlled room (20 - 22°C) with a diet of 
rodent chow, carrots, apples, sunflower seeds and water ad lid on a 12 h light/dark cycle. 
All animal experimental protocols were approved by the Institutional Animal Care and 
Use Committee of the University of Alaska Fairbanks.
2.2. Stereotaxic Surgery
The ground squirrels were fasted for at least 4 h before the surgical insertion of 
telemetry transmitters (model VM-FH, Minimitter, OR) and guide cannulae (CMA, 
Acton, MA). Surgery was performed under general anesthesia with halothane 
(Halocarbon Lab, Riveredge, NJ), induced at 5%, and maintained at 2.5-3% mixed with 
100% medical grade O2 at a flow rate of 1.5 L/ml. Surgery was performed under strictly 
aseptic conditions (Surgical Packs for Stereotaxic Surgery are listed in appendix I). Body
temperature was kept at 36.5-37.5 °C with a fluid-filled heating pad (Omni medical 
equipment, Cincinnati, OH) throughout the surgery. Precalibrated, wax-coated telemetry 
transmitters used to monitor the body temperatures were inserted intraperitoneally. The 
ground squirrels were placed in a rat stereotaxic frame (Stoelting, Wooddale, IL) and the 
skull was leveled at the points of ear bar zero (EBZ) + 10.0 mm and EBZ + 30.0 mm.
The nose bar was then positioned at -  20.0 mm relative to the value at level head. Guide 
cannulae, containing the obturators, were stereotaxically implanted with their tips into the 
right and left striatum (AP = 13.5 mm if Frontal Nasal Suture (FNS) to EBZ < 30 mm, or 
14 mm if FNS to EBZ >30 mm, L = ± 3.25mm, D = — 4mm) (all the detail calculation 
procedures are indicated in the appendix II). Four anchor stainless steel screws (BAS, 
West Lafaette, IN) were implanted into the skull and secured to the base of the guide 
cannulae with dental cement (Hygenic repair resin, Hygenic Corp, Akron, Ohio).
To eliminate incidence of infection, in addition to the aseptic surgical technique:
1) animals were treated with antibiotic (enrofloxacin, 5mg/kg, sc) one day before surgery 
and two days postoperatively; 2 ) for 10 days post-operation, animals were housed 
individually in stainless steel cages with nesting cotton but without wood shavings; 3) 
during this 10 day period, wounds were inspected and cleaned daily with 3% betadine 
diluted in 0.9% sterile saline.
Following 10 days post-op recovery, the animals, housed individually under a 
light regime of 12:12 h light: dark at 20-22°C , were transferred to the cold chamber with 
an ambient temperature of 2-4°C on a 4:20 h light: dark cycle, an environmental 
condition approximating the winter season. Hibernation was observed using the shavings
10
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added technique. Briefly, the animal was noted to be hibernating if wood shavings 
placed on their backs were not disturbed for about 24 hours. Body temperature was then 
monitored by telemetry at least 1 day prior to and throughout the microdialysis 
experiment to verify hibernating state. Animals that remained active were used as cold- 
adapted euthermic controls.
2.3. Microdialysis
Microdialysis was first described in the 1970s (Delgado et al., 1972) and has been 
used extensively in experimental studies in various tissues including brain. It is a well- 
established technique allowing the measurement of many low-molecular-weight 
substances in the extracellular space. The method relies on the diffusion of dissolved 
molecules surrounding a microdialysis probe across a semipermeable dialysis membrane 
into the probe. Nonetheless, insertion of guide cannulae and microdialysis probes into 
the brain produce a good model of penetrating brain injury. Therefore, the tissue 
response around the probe (or cannula) track is comparable to traumatic injury.
Artificial cerebral spinal fluid (aCSF), used for perfusing the microdialysis probes 
in all the in vivo and in vitro experiments, contained 124 mM NaCl, 2.7 mM KC1, 1.2 
mM CaCb, 0.85 mM MgCh, 1.4 mM glucose and 24 mM NaHCC>3, adjusted to pH = 7.4, 
P02 = 7 0 -  80 mm Hg, Pco2 = 30 -40  mm Hg by bubbling with 95% N2 / 5% CO2. A 
flow rate of 0.05 or 0.1 pL/min is recommended to investigate the extracellular 
concentrations of neurotransmitters since such slow flow rate has been determined to 
yield 100% in vivo recovery regardless of body temperature (Osbomet et al., 1999).
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2.3.1. In Vivo Microdialysis
All in vivo microdialysis experiments were performed in the hibemaculum with
an ambient temperature of 2-4 °C. Therefore, the perfusion fluid (aCSF) was the same 
temperature for both euthermic and hibernating groups.
Standard in viomicrodialvsis technique: In standard microdialysis
experiments, microdialysis probes (0.5 mm in diameter with a 4 mm dialyzing 
membrane; CMA/12, Acton, MA) were soaked in 70% ethanol for 10 min to wash out 
the glycerol. Using a microperfusion syringe pump, FEP tubings (1.2 pL/100 mm) 
connected to gas-tight glass syringes (CMA, Acton, MA) were rinsed with 1.0 M HC1 at 
a flow rate of 20 pL/min for 10 min followed by Milli-Q purified H2O at the same flow 
rate for another 10 min. The probes were connected with FEP tubing and perfused with 
freshly prepared aCSF (described above) at a flow rate of 0.6 pL/min for 20 min. The 
probes were then inserted into the striatum through the guide cannulae while animals 
were hibernating or euthermic. Euthermic animals were under slight anesthesia with 
halothane when probes were inserted.
Hourly samples were collected consecutively at a flow rate of 0.6 pL/min for 5 h, 
then the flow rate was decreased to 0.05 or 0.1 pL/min and an overnight sample was 
collected for a 15-17 h period. Such slow flow rates have been determined to yield 100% 
in vivo recovery for both hibernating and euthermic body temperatures (Osborne et al., 
1999). This perfusion protocol was repeated for 3 days in euthermic and 5 days in
hibernating squirrels. The dialysate samples were frozen and stored at -  80°C until 
HPLC analyses (see below).
Sterile in viomicrodialvsis technique; The experimental protocol and the
sampling procedure of the sterile microdialysis technique were the same as described in 
the standard procedure, except that, all components of the microdialysis system were 
sterilized and the experimental procedure was performed under aseptic conditions.
Probes were sterilized with ethylene oxide (Anprolene, Andersen Products, Haw River, 
NC). Milli-Q purified H2O, gas-tight glass syringes and FEP tubing as well as other 
instruments were autoclaved (121°C, 15 psi for 20 min) and aCSF was filter sterilized 
(0.2 pm, Acrodisc, Pall Corporation, Ann Arbor, MI) using aseptic technique. FEP 
tubing and probes were rinsed with sterile Milli-Q purified H2O for 10 min at a flow rate 
of 20 pL/min followed by aCSF perfusion at a flow rate of 0.6 pL/min for 20 min. 
Insertion of microdialysis probes and sample collection were performed using sterile 
technique. Dialysate was collected into autoclaved polypropylene 250 pL centrifuge 
tubes. Samples were collected for three days in both hibernating and euthermic animals.
Leukocyte counts were performed to assess leukocytopenia during hibernation 
and to monitor evidence of infection. In operated animals, blood was sampled via toe 
clip during surgery. Of these animals that remained euthermic, blood was sampled on the 
first day of the experiment via toe clip and on the last day of experiment via cardiac 
puncture at the time of euthanasia. In operated animals that entered hibernation blood 
was sampled via heart puncture at the time of euthanasia. In un-operated control animals
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(hibernating and euthermic), blood was sampled via cardiac puncture at the time of 
euthanasia. Using a microcollection system (unopette), blood was collected into 
heparinized tubes. The total white blood cells were counted manually (1:100 diluted with 
2.86% Glacial Acetic Acid solution) using a hemacytometer or automatically on a 
Coulter T-890 (Miami, FL) within 24 hours of sampling.
2.3.2. In Vitro Microdialysis
The in vitro sampling procedure was the same as in vivo experiments except that 
using an in vitro stand (CMA, Acton, MA), probes were placed in a liquid medium
(broth), containing 19 mM glutamine, 34 mM Na2HP0 4 , 33 mM KH2PO4, 2.0 mM 
MgSC>4 50 mg/L ferric ammonium citrate, 45 pM 5.5 mM glucose, and were
incubated at 37 °C in a water bath during three days of dialysis.
2.4. HPLC Analyses of Glutamate
Method 1: Dialysates (2 pL) were derivitized with 2 pL of o-phthaldialdehyde 
reagent (1.0 mL of OPA incomplete, Sigma, mixed with 14 pL mercaptoethanol solution 
diluted in methanol 1:10) in a 250 pL centrifuge tube. After a 2 minutes reaction time,
3.5 pL of the sample was injected onto a microbore column (Pronexus, Stockholm, 
Sweden) and separated using a mobile phase of 0.1 M acetate buffer including 10% 
acetonitrile at pH 6.0. Derivatives of glutamate were detected using a CMA/280 
fluorescence detector (CMA, Acton, MA) and recorded on a computer using 
Chromatography Station for Windows (CSW) software (Pronexus, Stockholm, Sweden).
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Method 2: Dialysates (10 pL ) were derivitized for 2 min with 10 pL OP A 
reagent with 1.34 mg o-phthaldialdehyde (EM, Gibbstown, NJ) mixed with 0.75 mL 
methanol, 0.25 mL 0.1M borate buffer (adjusted pH to 9.5 using 10 M NaOH) and 15 pL 
mercaptoethanal diluted in methanol 1:10. Then the derivitized dialysates were separated 
on a 10 cm RP column with guard using a mobile phase of 1.0 M sodium acetate (pH =
6.5, adjusted by acetic acid), 2.5% tetrahydrofuran and 25% methanol, pumped at 0.6 
mL/min by a Waters 510 pump. The detector was the same as system 1 and the 
glutamate peak heights were quantified on a Spectra-Physics 4270 integrator with the 
retention time (RT) at approximately 3.75 min.
In both HPLC systems, glutamate concentration was quantified by comparing 
peak height to an external standard. All chemicals of the highest purity available were 
obtained from Sigma (Louis, MO) unless otherwise noted.
2.5. Histology
After 3 days of microdialysis sampling, the euthermic animals were anesthetized 
with halothane while hibemators were not initially anesthetized. Rectal temperature was 
measured using a thermocouple in hibernating or anesthetized euthermic animals and 
blood was sampled via cardiac puncture. All animals were administered an intracardial 
injection of ketamine (2 mg/kg) and xylazine (0.6 mg/kg) prior to CSF sampling. Then 
under deep anesthesia, animals were perfused transcardially with at least 500 ml 0 .9% 
NaCl until clear. Following decapitation, brains were quickly removed and placed 
overnight in ice-cold methacam (60% methanol, 30% chloroform, 10% acetic acid) with
15
gentle shaking, then transferred to 70% isopropyl alcohol and stored at 4°C until paraffin 
embedding.
Prior to paraffin embedding, the whole brain was trimmed, perpendicular to the 
probe track, into three parts similar in thickness (Fig.l). Following conventional tissue 
processing procedure (Citadel 2000 Shandon, Pittsburgh, PA) each part of brain tissue 
was embedded in paraffin and 6 pm thick, consecutive sections were prepared on a 
sliding microtome for further analysis. Hematoxylin and eosin (H&E) staining were 
performed on sections around probes and guide cannulae of hibernating (n = 4  striata) 
and euthermic (n = 6 striata) tissue to investigate pathological tissue response following 
traumatic brain injury. Sections were processed with conventional histological 
techniques to determine the location of the probes. In all cases, probes were found to be 
located in the striatum.
2.6. Immunocytochemistry (ICC)
The non-aldehyde fixed (methacam) brain tissue sections of hibernating and 
euthermic squirrels were hydrated through graded ethanol after deparaffmization with 
xylene. Endogenous peroxidase activity in the tissue was inhibited by incubation in 3% 
hydrogen peroxide in methanol for 30 min. Sections were then incubated with 10% 
normal goat serum (NGS) in Tris-buffered saline (TBS; 50 mM Tris-HCl, 150 mM NaCl, 
pH=7.6) for 30 min at room temperature to eliminate non-specific binding. All washes 
and the dilutions of antibody were in 1% NGS in TBS. After washing, the sections were 
incubated overnight at 4°C with either (i) immunoaffinity purified rabbit polyclonal
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antibody against GFAP (1:1000) (glial fibrillary acidic protein, kind gift from Dr. 
Gambetti), used as an established marker for reactive astrocytes, or (ii) biotinylated RCA- 
1(1:300) (Vector Laboratories, Inc., Burlingame, CA) that recognizes microglia or (iii) 
immunoaffinity purified rabbit polyclonal antibody against HO-1 (Stressgen 
Biotechnologies Corporation, Inc., Victoria, BC, Canada) which is used as an oxidative 
stress marker. Sections stained by GFAP and HO-1 were then incubated in goat anti­
rabbit (ICN, Costa Mesa, CA) antisera for 30 min followed by rabbit-specific peroxidase- 
antiperoxidase complex for 1 hr (Stemberger Monoclonals Inc. and ICN, Cappel): and 
the staining was developed using 3.3'-diaminobenzidine (DAB) (DAKO Corp., 
Carpinteria, CA). Sections treated with RCA-1 were incubated with avidin D peroxidase 
(Vector Laboratories, Inc., Burlingame, CA) for 1 hr and then developed by DAB. The 
sections were then dehydrated through ascending ethanol and xylene solutions for 
mounting.
2.7. Statistics
Dialysate concentrations of glutamate in euthermic and hibernating animals are 
expressed as means ± SEM. Data collected in vivo were analyzed using a 2 x 2, repeated 
measures ANOVA design followed, when appropriate, by one-way ANOVAs and Tukey 
post-hoc comparisons. In vitro results were analyzed using a one-way repeated measures 
ANOVA design (SAS for windows, version 8 . SAS Institute Inc., Cary, NC). All sample 
analyses were performed on raw data.
Effects of surgery and hibernation state on white blood cell counts obtained on the 
last day of dialysis was determined using a 2x2 ANOVA design followed by Tukey post- 
hoc comparisons. Within animal comparisons across time for white blood cell counts in 
euthermic animals were made using a repeated measures ANOVA design (SAS for 
Windows, Version 8 . SAS Institute Inc., Cary, NC). The criterion for statistical 
significance was p < 0.05.
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Abstract
Hibernation, a natural model of tolerance to "cerebral ischemia", represents a state 
of pronounced fluctuation in cerebral blood flow where no brain damage occurs. 
Numerous neuroprotective aspects may contribute in concert to such tolerance. The 
purpose of this study was to determine if hibernating brain tissue is tolerant to penetrating 
brain injury modeled by insertion of microdialysis probes. Guide cannulae were 
surgically implanted in striatum of arctic ground squirrels before any of the animals 
began to hibernate. Microdialysis probes were then inserted in some animals after they 
entered hibernation and in others while they remained euthermic. The brain tissue from 
hibernating and euthermic animals was examined 3 days after implantation of 
microdialysis probes. Tissue response, indicated by examination of H&E stained tissue 
sections and immunocytochemical identification of activated microglia, astrocytes and 
HO-1 immunoreactivity, was dramatically attenuated around probe tracks in hibernating 
animals compared to euthermic controls. No difference in tissue response around guide 
cannulae was observed between groups. Further study of the mechanisms underlying 
neuroprotective aspects of hibernation may lead to novel therapeutic strategies for stroke 
and traumatic brain injury.
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Introduction
Clinical and experimental studies show that following CNS trauma, such as 
traumatic brain injury (TBI) and acute ischemic stroke, neuronal damage continues to 
progress after the initial insult (Petito et al., 1987; Heiss et al., 1992; Garcia, 1992; 
McIntosh et al., 1998). Ischemia and TBI share several common neurodegenerative 
mechanisms including excitotoxicity, perturbation of Ca2+ homeostasis, inflammation and 
oxidative stress (Rothman and Olney, 1986; Faden et al., 1989; Vila et al., 2000; Berry 
and Logan, 1999; Nagayama et al., 2000; Shohami et al., 1997). Furthermore, the 
pathological events in Alzheimer disease and late onset dementia may be triggered by or, 
at minimum, exacerbated by, impaired cerebral perfusion originating in the 
microvasculature and are associated with increased inflammation and oxidative stress 
(Shi et al., 2000). Despite numerous therapeutic strategies found to reduce ischemia- 
induced damage in experimental models, only tissue plasminogen activator (TPA) has 
proven effective in controlled clinical trials (The NINDS rt-PA Study Group, 1995; 
Wardlaw et al., 1997; Wahlgren, 1997). While TPA has improved prognosis for many 
stroke patients, progress in the development of effective pharmacotherapies for ischemia, 
TBI and neurodegenerative disorders has been slow.
Hibernation is a unique physiological condition known best for suppression of 
metabolism and body temperature which is thought to promote survival during periods of 
food shortage (Lyman, 1948). Less well recognized are the numerous, potentially 
neuroprotective aspects of hibernation physiology such as leukocytopenia, 
immunosuppression, inhibition of protein synthesis, enhanced antioxidant defense and
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metabolic suppression (Lyman, 1948; Snapp and Heller, 1981; Sidky rt al., 1969; 
Mckenna and Musacchia 1968; Frerichs et al., 1994; Frerichs et al., 1998; Gentile et al., 
1996; Drew et al., 1999; Toein et al., 2001). Consistent with the hypothesis that 
hibernation is neuroprotective, Frerichs and Hallenbeck reported increased tolerance to 
hypoxia/aglycemia in hippocampal slices in vitro from hibernating thirteen-lined ground 
squirrels. Moreover, in previous microdialysis studies in our lab (Osborne et al., 1999), 
hibernating and euthermic arctic ground squirrels were readily distinguished on the bases 
of tissue response around the microdialysis probe (Hu et al., 1998). In these previous 
studies, however, probes were in place longer in hibernating than euthermic animals and 
sterile microdialysis technique was not followed. The purpose of the present study was 
therefore to modify these experiments to systematically determine how tolerant 
hibernating brain tissue is to CNS trauma, in vivo, where multiple potentially 
neuroprotective mechanisms may act in concert.
Microdialysis is a well-established and accepted method for sampling 
neurotransmitter overflow in awake, freely moving animals. The technique has proven 
effective in numerous applications where correlations in neurotransmitter release and 
behavior are verified by pharmacological manipulations (Porkka-Heiskanen et al., 1997; 
Tanda et al., 1997). Nonetheless, insertion of guide cannulae and microdialysis probes 
into brain tissue produce stab-like wounds characteristic of traumatic brain injury with 
associated release of IL-1J3 (Woodroofe et al., 1991), gliosis (Woodroofe et al., 1991; 
Benveniste and Diemer, 1987), infiltration of granulocytes (de Lange et al., 1995) and 
neuronal degeneration (Clapp-Lilly et al., 1999). In the present study we assessed tissue
pathology around microdialysis probes and guide cannulae in euthermic and hibernating 
arctic ground squirrels to test the hypothesis that hibernation attenuates the post-traumatic 
tissue response seen with brain injury. Results show marked differences in traumatic 
tissue response in hibernating versus euthermic animals.
Methods
Surgery
All procedures were approved by the Institutional Animal Care and Use 
Committee. The animals used in this study were male and female arctic ground squirrels 
(AGS) weighing 650-840 (g) at the time of surgery. Surgery was performed under 
general anesthesia with halothane (Halocarbon Lab, Riveredge, NJ), induced at 5%, and 
maintained at 2.5-3% mixed with 100% medical grade O2 at a flow rate of 1.5 L/ml. 
Surgery was performed under strictly aseptic conditions. Telemetry transmitters (model 
VM-FH, Minimitter, OR) used to monitor core body temperature, were implanted 
intraperitoneally. Ground squirrels, fasted at least 12 hours prior to the surgery, were 
secured in a stereotaxic frame. Guide cannulae (CMA, Acton. MA) were stereotaxically 
positioned above the right and left striatum (AP=13.5 or 14mm, L= ± 3.25mm, D= -  
4.0mm) described in detail by Osborne et al. (1999), and were slowly lowered 4mm from 
the cortical surface. Four anchor stainless steel screws (BAS, West Lafaette, IN) were 
placed on the skull. Cannulae were secured to the screws with dental cement. Antibiotic
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(enrofloxacin 5mg/kg) was given 1 day before surgery and 2 days postoperatively by 
subcutaneous injection.
Following 10 days post-op recovery, the animals, housed individually under a 
light regime of 12:12 h light: dark at 20-22°C , were transferred to the cold chamber with 
an ambient temperature of 2-4°C on a 4:20 h light: dark cycle. Hibernation was observed 
using the shavings added technique. Briefly, the animal was noted to be hibernating if 
wood shavings placed on the back remained overnight. Body temperature was then 
monitored by telemetry at least 1 day prior to and throughout the microdialysis 
experiment to verify hibernating state.
Microdialysis
Microdialysis procedures and experimental protocol were the same as described 
in detail by Osborne et al.(1999), except that in the present study, all components of the 
microdialysis system were sterilized via heat (autoclave), ethylene oxide (Anprolene, 
Andersen Products, Haw River, NC) or 0.2 pm filtration (Acrodisc, Pall Corporation,
Ann Arbor, MI). Briefly, the continuously perfused microdialysis probes (CMA 12/04, 
O.D. = 0.5mm) were slowly inserted into the right and left striatum through guide 
cannulae while animals were hibernating or euthermic. Euthermic animals were lightly 
anesthetized with halothane, induced as described for surgery, maintained at 1% for 
approximately 5 min. Euthermic animals recovered from anesthesia within about 15 min 
of inserting probes. Microdialysis probes were perfused by means of a CMA/102 syringe 
pump with artificial cerebral spinal fluid (aCSF contained 124 mM NaCl, 2.7 mM KC1, 
1.2 mM CaCh, 0.85 mM MgCb, 1.4 mM glucose, 24 mM NaHCC>3, adjusted to pH =
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7.4, P02 = 70-80 mmHg, Pco2 = 30-40 mmHg by bubbling with 95% N2 / 5% CO2). The 
perfusion protocol, 0.6 pl/min for 5 h; 0.1 pl/min for overnight, was repeated 3 days in all 
hibernating and euthermic animals. All microdialysis experiments were performed in the 
hibemaculum with an ambient temperature of 2-4 °C. Therefore, the perfusion fluid 
(aCSF) was the same temperature for both euthermic and hibernating groups.
Dialysate collected at 0.6 pl/min during the day or 0.1 pl/min overnight was 
analyzed for glutamate by High Pressure Liquid Chromatography (HPLC) coupled with 
fluorescence detection. Dialysates were derivitized with o-phthaldialdehyde reagent [1.0 
ml of OPA incomplete (Sigma, St.Louis, MO), mixed with 14ul mercaptoethanol 
solution diluted in methanol in 1:10] and separated on a microbore column (Pronexus, 
Stockholm, Sweden) using a mobile phase of 0.1 M acetate buffer including 10% 
acetonitrile at pH 6.0. Derivatives of glutamate were detected using a CMA/280 
fluorescence detector (CMA, Acton, MA) and recorded on the computer via 
Chromatography Station for Windows (CSW) software (Pronexus, Stockholm, Sweden). 
Glutamate concentration was quantified by comparing peak height to an external 
standard.
Total white blood cell counts were performed to assess leukocytopenia during 
hibernation and to monitor evidence of infection. In operated animals, blood was 
sampled via toe clip during surgery. Of these animals that remained euthermic, blood 
was sampled on the first day of the experiment via toe clip and on the last day of 
experiment via cardiac puncture at the time of euthanasia. In operated animals that 
entered hibernation blood was sampled via heart puncture at the time of euthanasia. In
un-operated control animals (hibernating and euthermic), blood was sampled via cardiac 
puncture at the time of euthanasia. Using a microcollection system (unopette), blood was 
collected into heparinized tubes. The total white blood cells were counted manually 
(1:100 diluted with 2.86% Glacial Acetic Acid solution) using a hemacytometer or 
automatically on a Coulter T-890 (Miami, FL) within 24 hours of sampling.
Tissue Preparation
After 3 days of microdialysis sampling, the euthermic animals were anesthetized 
with halothane while hibemators were not initially anesthetized. Rectal temperature was 
measured using a thermocouple in hibernating or anesthetized euthermic animals and 
blood was sampled via cardiac puncture. All animals were administered an intracardial 
injection of ketamine (2 mg/kg) and xylazine (0.6 mg/kg) prior to CSF sampling as 
described in Drew et al., (1999). Then under deep anesthesia, animals were perfused 
transcardially with at least 500 ml 0.9% NaCl until clear. Following decapitation, brains 
were quickly removed and placed overnight in ice-cold methacam (60% methanol, 30% 
chloroform, 10% acetic acid) with gentle shaking, then transferred to 70% isopropyl 
alcohol and stored at 4°C until paraffin embedding.
Histology
Prior to paraffin embedding, the whole brain was trimmed, perpendicular to the 
probe track, into three parts similar in thickness (Fig.l). Following conventional tissue 
processing procedure (Citadel 2000 Shandon, Pittsburgh, PA) each part of brain tissue 
was embedded in paraffin and 6 pm thick, consecutive sections were prepared on a 
sliding microtome for further analysis. Hematoxylin and eosin (H&E) staining were
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performed on sections around probes and guide cannulae of hibernating (n = 4 striata) 
and euthermic (n = 6 striata) tissue to investigate pathological tissue response following 
traumatic brain injury.
Immunocytochemistry (ICC)
The non-aldehyde fixed (methacam) brain tissue sections of hibernating and 
euthermic squirrels were hydrated through graded ethanol after deparaffinization with 
xylene. Endogenous peroxidase activity in the tissue was inhibited by incubation in 3% 
hydrogen peroxide in methanol for 30 min. Sections were then incubated with 10% 
normal goat serum (NGS) in Tris-buffered saline (TBS; 50 mM Tris-HCl, 150 mM NaCl, 
pH=7.6) for 30 min at room temperature to eliminate non-specific binding. All washes 
and the dilutions of antibody were in 1% NGS in TBS. After washing, the sections were 
incubated overnight at 4°C with either (i) immunoaffinity purified rabbit polyclonal 
antibody against GFAP (1:1000) (glial fibrillary acidic protein, kind gift from Dr. 
Gambetti), used as an established marker for reactive astrocytes, or (ii) biotinylated RCA- 
1(1:300) (Vector Laboratories, Inc., Burlingame, CA) that recognizes microglia 
(Mannoji et al., 1986), or (iii) immunoaffinity purified rabbit polyclonal antibody against 
HO-1 (Stressgen Biotechnologies Corporation, Inc., Victoria, BC, Canada) which is used 
as an oxidative stress marker. Sections stained by GFAP and HO-1 were then incubated 
in goat anti-rabbit (ICN, Costa Mesa, CA) antisera for 30 min followed by rabbit-specific 
peroxidase-antiperoxidase complex for 1 hr (Stemberger Monoclonals Inc. and ICN, 
Cappel): and the staining was developed using 3.3'-diaminobenzidine (DAB) (DAKO 
Corp., Carpinteria, CA). Sections treated with RCA-1 were incubated with avidin D
peroxidase (Vector Laboratories, Inc., Burlingame, CA) for 1 hr and then developed by 
DAB. The sections were then dehydrated through ascending ethanol and xylene 
solutions for mounting.
Statistics
Effects of surgery and hibernation state on white blood cell counts obtained on the 
last day of dialysis was determined using a 2x2 ANOVA design followed by Tukey post- 
hoc comparisons. Within animal comparisons across time for white blood cell counts in 
euthermic animals and dialysate concentrations of glutamate in euthermic and hibernating 
animals were made using a repeated measures ANOVA design (SAS for Windows, 
Version 8 . SAS Institute Inc., Cary, NC).
Results
At the time probes were inserted, mean core body temperature (± SD, n=3-4) of 
euthermic animals was (35.9 ± 1.6 °C) and for hibernating animals was (4.1 ± 0.8 °C). 
Body temperature of hibernating animals remained low (less than 5 °C) throughout the 
dialysis sampling period. White blood cell counts decreased from 6357 ± 2739/mm3 in 
euthermic animals to 456 ± 98/mm3 in hibernating animals, (mean ± SD, n=8-10, 
p<0.0001 main effect of state) (Fig. 2). White blood cell counts were similar in the 
operated groups compared to un-operated control animals (p=0.31, main effect of 
surgery) (Fig. 2). White blood cell counts on the day of surgery and the first and last day 
of the experiment in euthermic animals also remained stable (mean ± SD; day of surgery,
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7583 /mm3 + 1443/mm3; day 1 of dialysis, 8812/mm3 ± 3071/mm3; last day of dialysis 
7343/mm3 ± 3360/mm3). Similar white blood cell counts in operated and un-operated 
animals and stability of counts during the duration of experimental protocol were 
consistent with clinical observations that operated animals were free of infection.
Microdialysis probe and guide cannulae tracks were easily distinguished based on 
position (depth) of placement and a clear difference in track diameter (Fig. 1). 
Examination of H&E stained tissue sections indicated an obvious response around the 
guide cannula in all hibernating and euthermic animals with no convincing difference 
among the cases (not shown). However, importantly, results from the sections with probe 
tracks showed a clear difference in tissue reaction between hibernating animals and 
controls (Fig.3). In the hibernating animals there was simply a small space surrounded 
by slightly pale neural parenchyma. Routine light microscopy showed no other cellular 
tissue response around the probe track. By contrast, euthermic animals showed a number 
of histological changes, including reactive astrocytosis, microglial activation, 
macrophage infiltrate, and axonal swellings.
Activated microglia, identified by using RCA-1 binding and amoeboid shape are 
clearly seen around the probe tract in euthermic tissue (n = 6 striata, Fig. 4A). In 
contrast, the probe tract is barely discemable in hibernating tissue (n = 4 striata, Fig. 4B). 
While resting, ramified microglia are seen throughout the hibernating tissue section, no 
activated microglia are present around the probe tract. Astrocytosis, also visible in H&E 
stained sections, was confirmed using antibodies against GFAP. GFAP 
immunoreactivity was more intense around the probe tracts in euthermic animals
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compared to hibernating animals (Fig. 4C,D). Hemeoxygenase-1 (HO-1) 
immunoreactivity, a marker of oxidative stress response induction, was localized 
primarily to glial cells and present around the probe tract in euthermic tissue (Fig. 4E). In 
contrast, HO-1 immunoreactivity was absent in hibernating tissue (Fig. 4F). The 
concentration of glutamate in the dialysate collected from the striatum at qualitative 0.6 
pl/min and 0.1 pl/min flow rates, stabilized by day 2 and remained stable over three days 
of dialysis. No significant difference was observed between euthermic and hibernating 
animals (data not shown).
Discussion
The present results revealed by histopathological analysis suggest that hibernation 
is neuroprotective. In euthermic brain tissue the typical inflammatory response was 
evidenced by i) the presence of activated microglia and astrocytes revealed by RCA-1 
binding and GFAP immunoreactivity, and ii) an oxidative stress response identified by 
an increase in HO-1 immunoreactivity. Both types of responses, however, were 
profoundly suppressed in hibernating animals.
Traumatic brain injury, induced by insertion of microdialysis probes, induces 
complex cellular reactions characterized by pathological alternations of neurons and glial 
cells, and release of inflammatory cytokines (Woodroofe et al., 1991; Benveniste and 
Diemer, 1987; de Lange et al., 1995; Clapp-Lilly et al., 1999). The glial response is 
referred to as reactive gliosis. Astrocytes, the major population of glial cells within the 
CNS, become reactive and increase expression of GFAP within the cytoplasm in
response to brain injury (Mathewson and Berry, 1985; Norenberg, 1994). Microglia, 
resident macrophages in the normal brain, are ubiquitous and readily transformed from a 
ramified resting state to an amoeboid activated appearance after trauma (Strite et al.,
1988; Kreutzberg, 1996). Release of neurotoxins from reactive glial cells contributes to 
neurodegeneration and increased neurotoxicity resulting in neuronal cell death (Hayes et 
al., 1992). The size of the probe tracks in euthermic striata (c.a. 100- 200 pm) were 
considerably larger than in hibernating striata yet still much smaller than the 500 pm
O.D. of the probe. Tissue adjacent to the probe likely dies by necrosis. Subsequent 
macrophage infiltrate, indicated in H & E staining and activated microglia in euthermic 
tissue, would then be expected to remove cellular debris, and contribute to the probe 
track in euthermic tissue (Fig. 3A and Fig. 4A,C). In contrast, less cell death and 
phagocytosis in hibernating tissue likely prevented the appearance of a well defined 
probe track (Fig. 3B and Fig. 4B,D). Importantly, a progressive increase in [glujdia was 
not associated with or necessary for the enhanced traumatic tissue response observed in 
the euthermic animals.
The significant degree of protection during hibernation likely results from a 
combination of factors, considering the number of potentially neuroprotective aspects of 
hibernation physiology. For example, small decreases in intra-ischemic brain 
temperature decreases the extent of ischemia-induced neuronal injury (Busto et al., 1987), 
and moderate hypothermia has been shown to hasten neurological recovery in patients 
with severe traumatic brain injury (Marion et al., 1997). While hypothermia has been 
shown to contribute to the neuroprotective state in hibernation (Frerichs and Hallenbeck,
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1998), it is unlikely that hypothermia is entirely responsible for the marked difference in 
brain tissue response.
Profound leukocytopenia, reported here for arctic ground squirrels, is another 
potentially neuroprotective hallmark of hibernation (Sidky et al., 1969; Frerichs et al., 
1994; Toein et al., 2001). Neutrophil adhesion and macrophage infiltration at sites of 
injury promote cytotoxic reactions (Weiss, 1989; Bowes et al., 1993; Whalen et al., 2000; 
Buzadzic et al., 1990). Thus leukocytopenia and decreased antibody formation (Mckenna 
and Musacchia, 1968) may protect hibernating brain tissue during injury. Plasma and 
cerebral spinal fluid concentrations of ascorbate increase significantly during hibernation 
(Drew et al., 1999; Toein et al., 2001) as do other antioxidant defense systems (Buzadzic 
et al., 1990). Increased antioxidant defense systems, therefore, may further protect 
hibernating brain tissue. The observation that HO-1, an antioxidant protein, is induced in 
euthermic but not in hibernating brain supports the hypothesis that hibernation minimizes 
injury-induced oxidative stress.
Inhibition of protein synthesis shown to be neuroprotective in a rodent model of 
focal ischemia-reperfusion (Du et al., 1996) also occurs during hibernation (Marion et al., 
1997; Knight et al., 2000). Thus, a number of potentially neuroprotective adaptations, in 
addition to profound hypothermia, leukocytopenia and metabolic suppression (Toein et 
al., 2 0 0 1 ), characterize hibernation and likely produce additive or synergistic 
neuroprotective effects.
The tissue response around the guide cannulae, which were implanted before any 
of the animals began to hibernate, was not significantly different between animals that
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remained euthermic and those that entered hibernation. This strongly suggests that the 
neuroprotective effect was due to the hibernation state and not to the difference between 
animals independent of the state of hibernation. While previous work in this lab (Clapp- 
Lilly et al., 1999) has shown, in rats, that perfusion of microdialysis probes has a 
tendency to enhance tissue damage, especially within 100 pm from the probe, the 
difference in tissue damage between dialyzed and non-dialyzed preparations is minor at 
both the light and ultrastructural level (Clapp-Lilly et al., 1999). This suggests that 
perfusion of the probe did not contribute appreciably to the degree of tissue response 
around the probe track. During the 6 to 8 month hibernation season, ground squirrels 
enter prolonged states of torpor (1-3 weeks) from which they periodically re-warm for 
brief (24-48 hrs) periods of euthermia. Speculation still exists as to what drives periodic 
arousal or why it is necessary. However, it is tempting to hypothesize that a combination 
of adaptations has evolved in parallel with hibernation to protect vulnerable tissues 
during frequent periodic re-warming. This same combination of adaptations likely 
accounts for the profound differences in traumatic brain injury reported here. Better 
understanding of mechanisms and neuroprotective effects of hibernation may ultimately 
contribute to the development of effective combination therapies for stroke, head trauma 
and possibly neurodegenerative disease.
In summary, the current study provides evidence that hibernation plays a crucial 
role in protecting brain tissue against traumatic injury induced by insertion of 
microdialysis probes. Many neuroprotective aspects of hibernation physiology, such as 
hypothermia, leukocytopenia, immunosuppression and enhanced antioxidant defense are
associated with tolerance to penetrating brain injury. Further efforts should be directed at 
identifying the mechanisms that regulate the suppression of cellular functions in 
hibernation. This could lead to new therapeutic strategies.
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Figure 1: Diagram of coronal view through striatum shows position of guide cannulae 
(outer dia. = 0.65 mm) and microdialysis probes (outer dia. = 0.5 mm with 4 mm long 
dialyzing membranes). Following fixation, brains were trimmed perpendicular to the 
probe tracks as indicated by dashed lines. Sections for histopathological analysis (6pm) 
were taken through cortex (C) and striatum (S), perpendicular to guide cannulae and 
microdialysis probe tracks.
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Figure 2: White blood cell (WBC) counts (mean ± SD) for operated and unoperated 
euthermic and hibernating arctic ground squirrels. Pooled (rectal) body temperature 
(mean ± SD, n=7-9) for euthermic was (36.46 + 0.97 °C) and for hibernating was ( 3.32 ± 
1.43 °C).

Figure 3: H&E stained sections in euthermic animals as compared with hibernating 
animals. A greater tissue reaction is seen in H&E stained sections in euthermic animals 
(A, C) as compared with hibernating animals (B, D). C and D are pictures with higher 
magnification of the area marked with (*) in A and B. Arrowheads point to the probe 
track. Sections from euthermic animals (A and C) demonstrate the probe cavity, 
accompanied by mononuclear inflammatory infiltrate, accumulation of lipid-laden 
macrophages (filled arrow), axonal swellings (open arrows) and fibrillary gliosis. In 
contrast, brain from hibernating animals (B and D) showed the probe cavity with no 
discernible inflammatory or reparative reaction. Specifically, no macrophages were seen, 
and there were no swollen axons or histological evidence of astrocytosis. There was 
simply a cavity surrounded by slight pallor of the surrounding neural parenchyma. Scale 
bar: A, B=100 pm, C, D=50 pm.
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Figure. 4: Immunocytochemical identification of activated microglia, astrocytes and 
HO-1 immunoreactivity. Activated microglia are visible around the probe tract (filled 
arrow) in euthermic tissue (A). In contrast, the probe tract (filled arrow) is barely 
discemable in hibernating tissue (B) where only resting (ramified) microglia (arrow) are 
seen. Scale bar: A,B=100pm. GFAP immunoreactivity around probe tract (filled arrow) 
is more intense in euthermic tissue (C) than hibernating tissue (D). Scale bar:
C,D= 100pm. Around probe tract (filled arrows in E and F) HO-1 immunoreactivity is 
seen in euthermic tissue (E) but is absent in hibernating tissue (F). Scale bar:
E,F= 100pm.
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Abstract
Glutamate is an excitotoxin that exacerbates tissue trauma following stroke and 
traumatic brain injury (TBI). Previous results in our lab showed decreased traumatic 
tissue response in hibernating compared to euthermic animals. The purpose of the 
present study was to determine if a progressive increase in glutamate is associated with 
increased tissue response observed previously in euthermic arctic ground squirrels 
(AGS). Using quantitative microdialysis in the striatum of AGS, we showed that 
dialysate glutamate concentrations ([glujdia) progressively increased to around 200 pM 
after 3 days in euthermic but not hibernating ground squirrels. While greater traumatic 
tissue response in euthermic animals could account for the increase in [glujdia we 
speculated that, given the vastly different body temperatures between the two groups 
(37°C vs. 4.5°C), glutamate might have originated from microbes, replicating at a faster 
rate in the warmer animals. To investigate this further, we: i) repeated the in vivo 
experiments with all components of the microdialysis system sterilized using ethylene 
oxide, heat (autoclave) or 0.2 pm filtration; and, ii) monitored dialysate glutamate 
concentrations collected in vitro from probes immersed in glutamine-rich liquid medium 
incubated at 37°C. Importantly, using a sterile microdialysis technique, we eliminated 
the progressive increase in glutamate in vivo as well as in vitro. These results suggest 
that microbial contamination can yield significant amounts of glutamate and could play 
important roles in the pathogenesis of penetrating brain injury and bacterial meningitis.
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Introduction
Glutamate, the principal excitatory neurotransmitter, is thought to be a critical 
factor common to a variety of neurological disorders, including ischemic stroke, 
traumatic brain injury (TBI) and neurodegenerative disorders (Schwarcz et al., 1981; 
Benveniste et ah, 1984; Choi and Rothman, 1990; Meldrum and Garthwaite, 1990;
Zauner and Bullock, 1995). Given the importance of glutamate, measuring the 
concentration of extracellular glutamate in the animal brain using microdialysis is a major 
research tool used by many laboratories to monitor extracellular levels of glutamate 
(Benveniste, 1989). While the technique has proven effective in numerous applications, 
insertion of microdialysis probes into brain tissue produces stab-like wounds 
characteristic of traumatic brain injury with associated release of IL-1|3 (Woodroofe et 
ah, 1991), gliosis (Woodroofe et ah, 1991; Benveniste and Diemer, 1987), infiltration of 
granulocytes (de Lange et ah, 1995) and neuronal degeneration (Clapp-Lilly et ah, 1999). 
Previously, we assessed tissue pathology around microdialysis probes in euthermic and 
hibernating arctic ground squirrels and found that hibernation attenuates the post- 
traumatic tissue response (Zhou et ah, 2001). Given the role of glutamate as an 
excitotoxin, the purpose of the present study was to determine if an increase in 
extracellular glutamate is associated with increased tissue response.
Methods
All animal experimental protocols were approved by the Institutional Animal 
Care and Use Committee of the University of Alaska Fairbanks. Microdialysis was
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performed in vivo as well as in vitro using sterile and standard microdialysis techniques.
Artificial cerebral spinal fluid (aCSF), used for perfusing the microdialysis probes 
in all the in vivo and in vitro experiments, contained 124 mM NaCl, 2.7 mM KC1, 1.2
mM CaCh, 0.85 mM MgCh, 1.4 mM glucose and 24 mM NaHCC>3, adjusted to pH = 7.4, 
P02 = 7 0 -80  mm Hg, PCO2 = 30-40  mm Hg by bubbling with 95% N2 / 5% CO2.
In vivo microdialysis 
Animals and surgery
Arctic ground squirrels were live-trapped in northern Alaska and transported to 
the Institute of Arctic Biology, University of Alaska Fairbanks. Male and female ground 
squirrels weighing 650- 840 g were housed individually in a temperature-controlled room 
(20 - 22°C) with a diet of rodent chow, carrots, apples, sunflower seeds and water ad lid 
on a 12 h light/dark cycle.
The ground squirrels were fasted for at least 4 h before the surgical insertion of 
telemetry transmitters (model VM-FH, Minimitter, OR) and guide cannulae (CMA, 
Acton, MA) as previously described (Osborne et al., 1999; Zhou et al., 2001). General 
anesthesia induced with halothane (Halocarbon Lab, Riveredge, NJ) at 5% was 
maintained at 2.5 - 3% mixed with 100% medical grade O2 at a flow rate of 1.5 L/min. 
Surgeries were performed under strictly aseptic conditions. Body temperature was kept 
at 36.5-37.5 °C with a fluid-filled heating pad (Omni medical equipment, Cincinnati, OH) 
throughout the surgery. Precalibrated, wax-coated telemetry transmitters used to monitor 
the body temperatures were inserted intraperitoneally. The ground squirrels were placed 
in a rat stereotaxic frame (Stoelting, Wooddale, IL) and the skull was leveled at the points
of ear bar zero (EBZ) + 10.0 mm and EBZ + 30.0 mm. The nose bar was then positioned 
at -  20.0 mm relative to the value at level head. Guide cannulae, containing the 
obturators, were stereotaxically implanted with their tips into the right and left striatum 
(AP = 13.5 mm if Frontal Nasal Suture (FNS) to EBZ < 30 mm, or 14 mm if FNS to EBZ 
>30 mm, L = ± 3.25mm, D = -  4mm). Four anchor stainless steel screws (BAS, West 
Lafaette, IN) were implanted into the skull and secured to the base of the guide cannulae 
with dental cement (Hygenic repair resin, Hygenic Corp, Akron, OH).
To eliminate incidence of infection, in addition to the aseptic surgical technique:
1) animals were treated with antibiotic (enrofloxacin, 5 mg/kg, sc, Bid) one day before 
surgery and two days postoperatively; 2) for 10 days post-operation, animals were 
housed individually in stainless steel cages with nesting cotton but without wood 
shavings; 3) during this 10 day period, wounds were inspected and cleaned daily with 
3% betadine.
After 10 days post-op recovery at 20 - 22°C, animals were transferred to a cold 
chamber with an ambient temperature of 2 - 4°C on a 4:20 h light/dark cycle, an 
environmental condition approximating the winter season. Animals were identified to be 
hibernating by using the previously described shaving added technique (Drew et al., 
1999). Body temperature was monitored via telemetry throughout microdialysis 
experiments. Animals that remained active were used as cold-adapted euthermic 
controls.
Standard microdialvsis technique
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In standard microdialysis experiments, microdialysis probes (0.5 mm in diameter 
with a 4 mm dialyzing membrane; CMA/12, Acton, MA) were soaked in 70% ethanol for 
10 min to wash out the glycerol. Using a microperfusion syringe pump, FEP tubing (1.2 
jllL/1 00 mm) connected to gas-tight glass syringes (CMA, Acton, MA) were rinsed with 
1.0 M HC1 at a flow rate of 20 pL/min for 10 min followed by Milli-Q purified H2O at 
the same flow rate for another 10 min. The probes were connected with FEP tubing and 
perfused with freshly prepared aCSF (described above) at a flow rate of 0.6 pL/min for 
20 min. The probes were then inserted into the striatum through the guide cannulae while 
animals were hibernating or euthermic. Euthermic animals were under slight anesthesia 
with halothane when probes were inserted.
Hourly samples were collected consecutively at a flow rate of 0.6 pL/min for 5 h, 
then the flow rate was decreased to 0.05 or 0.1 pL/min and an overnight sample was 
collected for a 15-17 h period. Such slow flow rates have been determined to yield 100% 
in vivo recovery for both hibernating and euthermic body temperatures (Osborne et al.,
1999). This perfusion protocol was repeated for 3 days in euthermic and 5 days in 
hibernating squirrels. The dialysate samples were frozen and stored at -  80°C until 
HPLC analyses (see below).
Sterile microdialvsis technique
For sterile microdialysis technique, the experimental protocol and the sampling 
procedure were the same as described in the standard procedure, except that in this study, 
all components of the microdialysis system were sterilized and the experimental 
procedure was performed under aseptic conditions. Probes were sterilized with ethylene
oxide (Anprolene, Andersen Products, Haw River, NC). Milli-Q purified H2O, gas-tight 
glass syringes and FEP tubing as well as other instruments were autoclaved (121°C, 15 
psi for 20 min) and aCSF was filter sterilized (0.2 pm, Acrodisc, Pall Corporation, Ann 
Arbor, MI) using aseptic technique. FEP tubing and probes were rinsed with sterile 
Milli-Q purified H2O for 10 min at a flow rate of 20 pL/min followed by aCSF perfusion 
at a flow rate of 0.6 pL/min for 20 min. Insertion of microdialysis probes and sample 
collection were performed using sterile technique. Dialysate samples were collected into 
autoclaved polypropylene 250 pL centrifuge tubes. Samples were collected for three 
days in both hibernating and euthermic animals.
Verification of probe placement
At the end of the microdialysis experiments, euthermic animals were anesthetized 
with halothane while hibemators were not anesthetized. Following decapitation, the 
brains were removed and fixed in methacam (60% methanol, 30% chloroform and 10% 
acetic acid). Sections were processed with conventional histological techniques to 
determine the location of the probes. In all cases, probes were found to be located in the 
striatum.
In vitro microdialysis
The in vitro sampling procedure was the same as in vivo experiments except that
using an in vitro stand (CMA, Acton, MA), probes were placed in a liquid medium 
(broth), containing 19 mM glutamine, 34 mM Na2HP0 4 , 33 mM KH2PO4, 2.0 mM
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MgS0 4  50 mg/L ferric ammonium citrate, 45 pM CaCh, 5.5 mM glucose, and were 
incubated at 37 °C in a water bath during three days of dialysis.
Two standard microdialysis techniques were performed: 1) Dialysis system was 
rinsed with 1.0 M HC1 followed by Milli-Q purified H2O before the aCSF perfusion, 
exactly as described in in vivo standard technique; or, 2) Dialysis system was rinsed with 
70% isopropyl alcohol followed by Milli-Q purified H2O before the aCSF perfusion. The 
flow rate and the duration for each rinsing period were the same for both standard 
techniques. The sterile in vitro microdialysis procedure was the same as in vivo sterile 
experiments.
HPLC analyses o f glutamate
Analyses of [glu]dia was performed by High Pressure Liquid Chromatography 
(HPLC) using one of the following two systems. System 1: Dialysates (2 pL) were 
derivitized with 2 pL of o-phthaldialdehyde reagent (1.0 mL of OP A incomplete, Sigma, 
mixed with 14 pL mercaptoethanol solution diluted in methanol 1:10) in a 250 pL 
centrifuge tube. After a 2 minutes reaction time, 3.5 pL of the sample was injected onto 
a microbore column (Pronexus, Stockholm, Sweden) and separated using a mobile phase 
of 0.1 M acetate buffer including 10% acetonitrile at pH 6.0. Derivatives of glutamate 
were detected using a CMA/280 fluorescence detector (CMA, Acton, MA) and recorded 
on a computer using Chromatography Station for Windows (CSW) software (Pronexus, 
Stockholm, Sweden). System 2: Dialysates (10 pL) were derivitized for 2 min with 10 
pL OPA reagent with 1.34 mg o-phthaldialdehyde (EM, Gibbstown, NJ) mixed with 0.75 
mL methanol, 0.25 mL 0.1M borate buffer (adjusted pH to 9.5 using 10 M NaOH) and
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15 jj.L mercaptoethanal diluted in methanol 1:10. Then the derivitized dialysates were 
separated on a 10 cm RP column with guard using a mobile phase of 1.0 M sodium 
acetate (pH = 6.5, adjusted by acetic acid), 2.5% tetrahydrofuran and 25% methanol, 
pumped at 0.6 mL/min by a Waters 510 pump. The detector was the same as system 1 
and the glutamate peak heights were quantified on a Spectra-Physics 4270 integrator with 
the retention time (RT) at approximately 3.75 min. In both HPLC systems, glutamate 
concentration was quantified by comparing peak height to an external standard. All 
chemicals of the highest purity available were obtained from Sigma (Louis, MO) unless 
otherwise noted.
Statistics
Data are expressed as means ± SEM. Data collected in vivo were analyzed using 
a 2 x 2, repeated measures ANOVA design followed, when appropriate, by one-way 
ANOVAs and Tukey post-hoc comparisons. In vitro results were analyzed using a one­
way repeated measures ANOVA design (SAS for windows, version 8. SAS Institute Inc., 
Cary, NC). All analyses were performed on raw data. The criterion for statistical 
significance was p < 0.05.
Results
In vivo evaluation
Using the standard microdialysis procedure, [glujdia collected at the flow rate of 
0.1 pL/min increased significantly (p < 0.05) in the euthermic arctic ground squirrels
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over three days, while [glu]dia remained stable (ranging between 1 to 2 pM for up to five 
days) in hibernating striatum (p = 0.1441; Fig.l A).
Interestingly, with the sterile microdialysis technique, the increase in [glujdia 
(collected at the flow rate of 0.1 pL/min) observed using standard technique in euthermic 
animals was completely eliminated. There were no significant differences between 
groups at any time point (p = 0.6961). Furthermore, the [glujdia decreased from day 1 to 
day 3 (p < 0.05) in both hibernating and euthermic animals (Fig. 1 B).
With the standard technique, the differences of [glujdia between groups was also 
observed in samples collected at 0.6 pL/min with the euthermic [glujdia higher than the 
hibemator’s (Fig. 2 A). There was no difference between groups or across time in 
samples collected at 0.6 pL/min with the sterile microdialysis technique (Fig. 2 B).
In vitro evaluation
With HC1 flushing of the dialysis system in vitro, the [glujdia increased 
significantly from day 1 to day 3 (p = 0.0014; Fig. 3). Flushing with 70% isopropyl 
alcohol produces a similar effect (p = 0.0348), error bar on day 3 reflects that in 4 out of 
7 experiments, [glujdia decreased from day 2 to day 3 (using HC1 5/5 increased from day 
2 to day 3; Fig. 3). The [glujdia observed in the HC1 group and the 70% isopropyl alcohol 
group corresponded to an increase of 458% and 527% of day 1 [glujdia, respectively. In 
contrast, the in vitro sterile microdialysis technique completely eliminated the increase in
glutamate concentration with [glujdia consistently remaining at the baseline level (Fig. 3). 
No significant change in [glujdia was noted within three days of experiments (p = 0.1940).
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Discussion
In the present study using standard microdialysis technique [glu]dia increased to 
around 200 pM over three days of dialysis in the striatum of euthermic (core body 
temperature, mean ± SEM, 36.94 ± 0.53 °C) but not hibernating (3.37 ± 0.03 °C) Arctic 
ground squirrels. Histological and immunocytochemical analyses showed a greater tissue 
response around the probe track in euthermic compared to hibernating animals (Zhou et 
al., 2001), prompting speculation that the increase in [glujdia was associated with greater 
tissue response. Given the vastly different body temperatures between the two groups, an 
alternative explanation was that glutamate originated from microbial contamination 
introduced by non-sterile microdialysis technique. To address the origin of the delayed 
increase in [glujdia, the present study measured glutamate overflow in the striatum of 
hibernating and euthermic ground squirrels as well as in vitro using standard and sterile 
microdialysis techniques. Results demonstrate that the sterile microdialysis technique 
eliminated a delayed increase in [glujdia both in vivo and vitro. The data indicate that 
the delayed increase in [glujdia observed in euthermic animals originated from microbial 
contamination showing conclusively that microbes can be a significant source of 
extracellular glutamate.
A number of studies, based on intracerebral microdialysis, have demonstrated that 
the concentration of glutamate increases immediately after the initial insult (i.e., 
penetration injury induced by insertion of microdialysis probes) (Nilsson et al., 1994, 
Obrenovitch and Urenjak, 1997; Faden et al., 1989). This initial increase in [glujdia was
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observed in the present study and is likely due to leakage of cytoplasmic glutamate 
through damaged plasma membranes.
A delayed increase of extracellular glutamate following traumatic brain injury has 
also been described. Indeed, glutamate concentrations continue to increase from hours to 
days after the primary insult (Bullock et al., 1995) and are thought to contribute to 
progressive tissue damage. Here we show that [glujdia in striatum of euthermic ground 
squirrels increased to 194 pM over three days using standard microdialysis technique. 
However, sterile microdialysis technique abolished this progressive increase in [glujdia- 
These data thus suggest that glutamate originated from microbes introduced by the non- 
sterile microdialysis technique. Consistent with vivo results, in vitro experiments 
further confirm the microbial origin of [glujdia- Using non-sterile technique, glutamate 
concentrations increased in vitro in the absence of traditional sources of glutamate 
including neurons, glia, macrophages or added protein. Furthermore, this increase was 
abolished using sterile microdialysis technique. This finding raises the possibility that 
microbial contamination may have confounded earlier microdialysis studies showing 
progressive increases in [glujdia- Furthermore, these results firmly establish that microbes 
can serve as a significant source of extracellular glutamate.
In clinical studies, neurological complications develop in up to 30% of patients 
with bacterial meningitis (Spranger et al., 1996). Furthermore, microbial infections can 
occur after neurosurgical procedures and have been found to be caused by a variety of 
organisms (Kaufaman et al., 1990). Microdialysis experiments have shown a close 
relationship between brain extracellular and cerebrospinal fluid (CSF) concentrations of
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excitatory amino acids in animal meningitis (Guerra et al., 1993). Spranger et al. (1996) 
reported that glutamate concentrations in the CSF of patients with bacterial meningitis 
were significantly elevated as compared to viral meningitis and non-inflammatory 
neurological disease, and that a high CSF concentration of glutamate was the best 
predictor of poor prognosis in long-term clinical outcome. Although monocytes and 
lymphocytes were found to release substantial amounts of glutamate in these bacterial 
meningitis studies, the source of the increased concentration of glutamate in the CSF 
during bacterial meningitis is still not fully understood. The present results suggest that 
microbes may be a significant source of extracellular glutamate and could contribute to 
neurodegeneration in bacterial meningitis and penetrating brain injury.
Certain bacterial genera (particularly Corynebacterium and Brevibacterium) 
contain species that excrete glutamate under certain growth conditions such as biotin 
limitation, or following the addition of antibiotics or surfactants. These conditions all 
lead to disruption of the cell membrane (Atlas, 1995). These organisms have been widely 
used in the commercial production of glutamate for its use as a flavor enhancer in foods 
(Glazer and Nikaido, 1995). However, these organisms generally reductively aminate a- 
ketoglutarate to produce glutamate, a reaction catalyzed by the enzyme glutamate 
dehydrogenase. This reaction is favored under low oxygen tensions (Glazier and 
Nikaido, 1995). Glutamate can also be formed via glutamine and a-ketoglutarate in the 
presence of excess glutamine, a reaction catalyzed by glutamate synthase (White, 1995). 
Microorganisms, including Escherichia coli, may produce high internal concentrations of 
glutamate as a response to hyperosmotic stress (Neidhardt et al., 1990). None of these
known conditions provides a full explanation for the increased glutamate, especially that 
seen in the in vitro medium under non-sterile conditions in this study, but does provide a
basis for microbial production and even significant secretion of glutamate under specific 
growth conditions.
In conclusion, these data clearly illustrate that the delayed increase in glutamate 
concentrations observed in striatum of euthermic ground squirrels using standard 
microdialysis technique is of microbial origin. Microbial glutamate may compromise 
neuronal health in some neuropathological conditions. Identity of the microbes involved 
and mechanisms responsible for microbial glutamate release remain areas for further 
study.
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Figure 5: Quantitative analysis of [glujdia by using standard and sterile microdialysis 
technique in vivo at the flow rate of 0.10 pL/min. Using standard microdialysis 
technique and quantitative flow rates (0.05 or 0.10 pL/mi n) (A), [glujdia significantly 
increases over 3 days of dialysis in euthermic striatum ( p < 0.05, day 3 vs. day 1 and day
2), while [glujdia remains stable for up to 5 days in hibernating striatum (p = 0.1441). The 
rise in [glujdia was abolished using sterile microdialysis technique where there were no 
significant differences between groups (B). Moreover, with the sterile technique, in both 
groups [glujdia decreased on day 2 and day 3 compared to day 1 (p < 0.05, day 1 vs. day 2 
and day 3). Error bars not seen are smaller than the symbol. Core body temperature of 
hibernating animals remained low (less than 5 °C) throughout the dialysis sampling 
period and for euthermic animals was (mean ± SEM) 36.63 ±0.41.
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Figure 6: Quantitative analysis of [glujdia by using standard and sterile microdialysis 
technique in vivo at the flow rate of 0.6 pL/min. The increase in [glu]dia was not as 
pronounced using standard technique (A) but was again attenuated with sterile 
microdialysis technique (B). Data shown are means ± SEM, n = 4 - 6. Core body 
temperature of hibernating animals remained low (less than 5 °C) throughout the dialysis 
sampling period and for euthermic animals was (mean ± SEM) 36.63 ±0.41.
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□ Day 1
Figure 7. In vitro analyses of [Glu]dia by using standard and sterile microdialysis 
technique. Using standard microdialysis techniques (HC1 and 70% isopropyl alcohol) in 
vitro, [glu]dia increased over 3 days when dialyzing tips were immersed in a liquid 
medium at 36.5-37.5 °C. Letters indicate significant difference (p < 0.05). Using sterile 
technique in vitro, no significant differences in [glu]dia were observed within 3 days (p = 
0.1940). Data shown are means ± SEM, n = 5 - 7 probes. Accumulation of glutamate 
after day 1 period was defined as 100% (In one set of experiment, the [glu]mediUm before 
inoculating bacteria was (mean ± SEM) 24.91 ± 3.88 pM; in another set of experiment, 
[glu]medium was 1073.30 ± 66.67 pM. Variation of [glu]medium was due to contamination 
of glutamine with glutamate). Samples were collected at 0.1 pL/min as described for 
vivo experiments.
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CHAPTER 4 
CONCLUSIONS
Aim 1 was to test the hypothesis that hibernating tissue is tolerant to penetrating 
brain injury. By using in vivo microdialysis, an excellent model of traumatic brain injury, 
evidence reported in this study supports the initial hypothesis. Tissue response, indicated 
by examination of H&E stained tissue sections and immunocytochemical identification of 
activated microglia, astrocytes and HO-1 immunoreactivity, was dramatically attenuated 
around probe tracks in hibernating animals compared to euthermic controls.
During hibernation, a number of potentially physiological adaptations, including 
profound hypothermia, leukocytopenia and increased antioxidant defense, likely produce 
additive or synergistic neuroprotective effects.
In aim 2, the hypothesis was an increase in [glujdia is necessary for progressive 
traumatic tissue response observed in euthermic animals in aim 1. However, the 
evidence reported in this study suggests that this delayed increase in glutamate is not 
necessarily associated with enhanced tissue response observed in euthermic tissue. The 
most interesting finding in addressing aim 3 may be that these significant amounts of 
glutamate can originate from microbial contamination that should be avoided by using 
sterile microdialysis technique.
Overall, the studies in this thesis provide evidence that hibernation plays a crucial 
role in protecting brain tissue against traumatic injury. The delayed increase in [glujdia 
characterized as microbial origin is not necessary for the enhanced traumatic tissue
response observed in euthermic compared to hibernating animals. Further efforts should 
be directed at understanding the mechanisms that regulate the suppression of cellular 
functions in hibernation as well as identification of the microbes involved and 
mechanisms responsible for microbial glutamate release.
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Appendix I 
Surgical Packs for Stereotaxic Surgery with Transmitter
Guide Cannulae Abdominal Stereotaxic Surgery Closing
Surgery
Gas Sterilize (at least 48 Autoclave in blue Autoclave in blue drape Autoclave in blue
hrs in advance)1 drape (Pack #2) (Pack #3)2 drape (Pack #4)
□  Guide Cannulae and □ Scalpel handle □ Gauze (1” pile) □ 3-0 Prolene,
plug with guide (for #15 blades) □ -20 cotton swabs FS-2 cutting
separated from plug □ Retractor (screw □ Scalpel handle (for #15) needle; (if left
(1 or 2/pack) type) □ Retractor (wire type) over).
□  Gel foam cut in ~lA x □ Blunt scissors or □ Curved forceps (4”) □ Hemostats or
Vi inch pieces hemostats □ Fine tipped forceps (5 needle: holder
(1/pack) □ Drape w/ 2” INOX, covered w/ pipet □ Blunt
□  Finger cots square tapped off tip, 4”) (straight or
(~ 10/pack) □ 1” pile of gauze □ Small drill bit to fit curveci)
□  Transmitters (1 /pack) □ Rat-toothed screws (bore type) forceps, 4 )
forceps (med-lg) □ Trephine drill bit (1” dia) □ Teflori tape
Autoclave in blue drape □ Needle holder and □ Screws (CMA or BAS) □ Scissors
(Pack #1) scissors □ 26 ga needle (bent) □ Cottoii swabs
□ Fine tipped □ Twisted tips of Kim wipes □ Gauze
□  2 guide cannulae forceps (straight) □ Paper clip (formed) for
holders □ Small blunt back of head stage
□  2 holders for guide forceps (straight) □ Pencils
cannulae holders □ Cotton swabs (~4) □ Screw driver that will fit
□ Prolene 3-0, FS-2 screws
needle (may be re­ □ Ceramic bowl
sterilized) □ Spatula
□ Eye dropper
□ (2) Curved hemostats
Extra Stuff
□  Surgery log sheet □ Betadine (full □  2% betadine □ Sterile saline
□  Anesthesia sheet strength) □  nitrofurazone □ 1 cc syringes
□  (2) #15 scalpel blades □ 70-75% isopropyl □  Tape w/ needles
□  Full halothane alcohol □  Digital thermometer (26-25 ga)
vaporizor □ Cotton gauze □  Eye lubricant (Lube- □ Clear
□  0 2 tank □ (4 packs) Sterile ide) cellophane
□  Halothane j ar with lid gloves □  Clear drape (Baxter) tape
fit with gas adapter □ ( 2 packs) Prolene (3- □  Nose cone for □ Surgery sheet
□  Nose cone for gas 0, FS-2 cutting needle) stereotax and pencil
□  H20  heating blanket for skin □  Stereotax w/ 2 arms □ Calculator
□  2 towels □ Chromic gut (T-5, 1 □  Ear bars for □ Dremel tool
□  Clippers, brush and mm needle) for muscle stereotax and variac (Be
spray □ Dexon (3-0, CE-4, 19 □  Dental cement sure drill bits
□  Gas sterilized mm needle) (Stoelting) fit in dremel
transmitter Chloramphenicol tool)
1 Gas sterilize using ethylene oxide at least 48 hrs in advance, but no more than 30 days in advance.
2 Mark a square ( - 5  x5 inch) in center of drape with autoclave tape
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Appendix II
Fast overnight or at least 4 hrs prior to surgery. Baytril, BID beginning 24 hr prior to surgery 
total of 3 davs (6 injections)
for a
Animal ID: Weight: Transmitter #:
Date: Sex: Head length (EBZ-FNS):
Circle side of stereotax used for coordinates: Left or Right
Record coordinates for Ear Bar Zero (EBZ) before animal is in stereotax.
Anterior Posterior (AP) Lateral (L)
FNZ
EBZ
A P fns-ebz
Be sure probe 
holders don’t bump.
If FNS-EBZ > 30 mm use +14.0 for AP coordinate; If FNS-EBZ < 30 mm use +13.5 for AP coordinate
AP EBZ"*"10 APebz+30 AP EBZ-*-10 Al’ebz+30
1. Dorsal coordinate 5. Dorsal coordinate
2. Dorsal coordinate 6. Dorsal coordinate
3. Dorsal coordinate 7. Dorsal coordinate
4. Dorsal coordinate 8. Dorsal coordinate
Record nose bar at level skull: 
Subtract 20 mm
Drop nose bar to level skull -  20mm 
Nose bar dropped to :____________
Calculate coordinates for right and left guide cannulae: Mark sites with pencile
Left RightCoordinates of 
Pencil marks 
A P ebz
+13.5 or 14mm
Coordinates 
on opposite 
side at mark
A P ebz
+13.5 or 14mm
Lebz  
± 3.25 mm
Dbrain surface
-4.00mm
Lebz 
± 3.25 mm
Dbrain surface
-4.00mm
Bring head to level position, Drill holes and insert screws, Drill holes for guide cannulae, Drop nose -  
20 mm, insert and cement guide cannulae in place. Administer Enrofloxacin (Baytril), 5mg/kg, sc 
back of neck, two times a day for three days beginning 24 hrs before surgery. Clip toenails and apply 
nitrofurazone. Clean surgical site(s) with 3% betadine once/day for 10 days.
Note: if lateral coordinate at EBZ is not on the midline, lateral position of guide cannulae will be relative 
to midline suture visible on the skull surface at the AP extent of EBZ.
